How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned?

Ozdemir, E Sila; Ranganathan, Srivathsan V; Nussinov, Ruth

Ozdemir, E Sila; Ranganathan, Srivathsan V; Nussinov, Ruth.

Ozdemir ES; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Ranganathan SV; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Nussinov R; Cancer Innovation Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA.

Expert Opin Drug Discov ; 17(10): 1061-1065, 2022 Oct.

Article in English | MEDLINE | ID: covidwho-2051060

Subject(s)

Artificial Intelligence; COVID-19 Drug Treatment; Humans; Drug Repositioning; Algorithms; Precision Medicine

Keywords

COVID-19; Drug repurposing; artificial intelligence; computational biology; knowledge graph; machine learning; personalized treatment; precision medicine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Artificial Intelligence / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Expert Opin Drug Discov Year: 2022 Document Type: Article Affiliation country: 17460441.2022.2128333

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google